Biotalys NV

Equities

BTLS

BE0974386188

Fishing & Farming

Real-time Euronext Bruxelles 06:58:21 2024-04-23 am EDT 5-day change 1st Jan Change
3.2 EUR +2.56% Intraday chart for Biotalys NV +8.84% -31.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG CI
Transcript : Biotalys NV, 2023 Earnings Call, Feb 22, 2024
Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Biotalys Inks Plant Pathology Research Agreements in Europe, US MT
Biotalys Announces Results of Independent Field Trials in the U.S CI
Transcript : Biotalys NV - Special Call
Biotalys' New CEO Takes Office MT
Belgium's Biotalys Appoints New CEO MT
Biotalys Announces Chief Executive Officer Changes CI
Biotalys Announces That Patrice Selles Will Then Step Down from His Position as Director CI
Transcript : Biotalys NV, H1 2023 Earnings Call, Aug 23, 2023
Biotalys NV Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Biotalys to Raise EUR7 Million from Share Sale MT
Biotalys NV announced that it expects to receive €6.999995 million in funding from Agri Investment Fund cvba, SFPIM-International CI
Biotalys, Syngenta Crop Protection Partner to Develop Sustainable Agriculture Technology MT
Syngenta Crop Protection and Biotalys Announces Collaboration to Develop New Biocontrol Solutions CI
Biotalys NV Announces Chief Financial Officer Changes CI
Transcript : Biotalys NV, 2022 Earnings Call, Feb 28, 2023
Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Biotalys Targets 2026 Release of Biofungicide After Hitting Production Efficiency Milestone MT
Biotalys Announces Establishment of a Scientific Advisory Committee CI
Biotalys Nv and Novozymes A/S Announces Successful Evoca™ Feasibility Study CI
Transcript : Biotalys NV, H1 2022 Earnings Call, Aug 19, 2022
Biotalys NV Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Biotalys NV
More charts
Biotalys NV specializes in the development of products for crop and food protection. The company offers advanced protein-based biocontrols that effectively and selectively target pests and pathogens, while maintaining the protection of the environment.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.12 EUR
Average target price
6 EUR
Spread / Average Target
+92.31%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BTLS Stock
  4. News Biotalys NV
  5. Biotalys Targets 2026 Release of Biofungicide After Hitting Production Efficiency Milestone